JPMA to Straighten Up Industry Positions on FY2018 Pricing Reform

JPMA Director General Tadaharu Goto The Japan Pharmaceutical Manufacturers Association (JPMA) will work to delineate its positions and views on the next drug pricing reform scheduled for April 2018 by sorting out challenges posed by the current system, JPMA Director...read more